Porphyria Educational Services
Porphyria Educational Services Weekly Bulletin
Vol. 2 No. 52 December 31, 2000
FOCUS: Latex Sensitivity
Utilization of latex free products in providing care for
porphyria patients with known or
identified latex allergies from additional exposure is a must.
Also it is important that
such products, especially gloves, also be "powder free".
Health care providers caring for porphyria patients should choose
l;atex free products
in providing care for patients with known or identified latex
allergies from additional exposure both during times of
exacerbation of their porphyria and during remission as well.
Exposure to latex could possibly be a trigger for some porphyria
patients with very sensitive cutaneous
aspects of porphyria.
.
Latex sensitivity can occur as an immediate hypersensitivity
resulting in difficulty breathing, anaphylaxis or to a lesser
extent five to thirty minutes after latex contact with symptoms
including hives, eczema, and/or facial swelling.
Other less severe reactions occur as delayed hypersensitivity six
to forty-eight hours after
contact or may result in an irritant dermatitis.
How does one know for sure if latex is a problem?
Positive results to intradermal testing, skin prick test (SPT) or
radiolallergosorbent (RAST) test are additional methods of
identifying persons with suspected latex sensitivity. It is
important to note here that many medical insurance providers do
not pay for random PAST testing.
Porphyria patients should have access to latex free supplies
which will enable their care to be provided in a safe, efficient
manner without exposure to elements known to trigger porphyria or
cause cutaneous or neurologic reaction.
In addition the following measures should be enacted for patients
with known latex sensitivities. Whether it be in a clinic setting
or hospital setting, there should be a
placement of allergy armband and/or a chart sticker that will
aleart all medical care
providers to the latex sensitivity.
When a porphyric patient goes into a hospital setting, scheduling
of a test or surgical procedure should be made as the first case
of the day when the environment is known to be the most allergen
free. Pre-procedure prophylactic treatment is not required but
may be given at the patient's medical care provider's discretion.
There should be a report on discharge summary so that reasonable
efforts will be made to
minimize additional exposure as the patient leaves their
isolation area and proceeds to
the main exit of the medical facility.
Prior to a porphyria patient's admission education and
information about latex sensitivity should be provided to all
staff.
However well executed the plan, there is always a chance that
exposure will occur. If a patient experiences a latex reaction.
It must be noted here in closing that any anaphylactic latex
reactions are required to be reported to the Center for Disease
Control (CDC).
Jill Williams, MNS
Special Procedures Coordinator